MARKET

MIRM

MIRM

Mirum Pharmaceuticals
NASDAQ
99.71
+1.48
+1.51%
Opening 12:45 08/12 EDT
OPEN
98.58
PREV CLOSE
98.23
HIGH
100.37
LOW
98.30
VOLUME
173.15K
TURNOVER
--
52 WEEK HIGH
130.00
52 WEEK LOW
58.48
MARKET CAP
6.47B
P/E (TTM)
-6.8541
1D
5D
1M
3M
1Y
5Y
1D
J.P. Morgan Keeps Their Buy Rating on Mirum Pharmaceuticals (MIRM)
TipRanks · 1d ago
Weekly Report: what happened at MIRM last week (0803-0807)?
Weekly Report · 2d ago
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Encompass Health (EHC)
TipRanks · 2d ago
Mirum Pharmaceuticals Price Target Cut to $140.00/Share From $145.00 by TD Cowen
Dow Jones · 5d ago
Mirum Pharmaceuticals Is Maintained at Buy by TD Cowen
Dow Jones · 5d ago
TD Cowen Maintains Buy on Mirum Pharmaceuticals, Lowers Price Target to $140
Benzinga · 5d ago
Mirum sinks after FDA recommends conducing Phase 3 study
TipRanks · 5d ago
Mirum Pharmaceuticals Is Maintained at Outperform by RBC Capital
Dow Jones · 5d ago
More
About MIRM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the treatment of rare diseases affecting children and adults. It has three medicines: LIVMARLI (maralixibat) oral solution (Livmarli), Cholbam (cholic acid) capsules, and Chenodal or Ctexli (chenodiol) tablets. Livmarli is an orally administered, minimally-absorbed ileal bile acid transporter (IBAT) inhibitor (IBATi) that is used for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the United States and various other countries and for cholestatic pruritus in patient with progressive familial intrahepatic cholestasis (PFIC) in the United States, Canada and Japan. Cholbam is used for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders. The Company is also advancing its product candidate, volixibat, for the treatment of adult patients with cholestatic liver diseases.

Webull offers Mirum Pharmaceuticals Inc stock information, including NASDAQ: MIRM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MIRM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MIRM stock methods without spending real money on the virtual paper trading platform.